GSK plc (GSK) Latest News

NYSE Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$43.34

south_east

-$0.35 (-0.8%)

Day's range

$43.04

$44.26

Latest News of GSK

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?

By Yahoo! Finance | 11 months ago

China's NMPA approves GSK's Nucala for CRSwNP treatment

China's NMPA approves GSK's Nucala for CRSwNP treatment

By Yahoo! Finance | 11 months ago

GSK's Nucala Gains Approval in China for CRSwNP

GSK's Nucala Gains Approval in China for CRSwNP

By Yahoo! Finance | 11 months ago

GSK's Sinus Disease Drug Secures Approval In China

GSK's Sinus Disease Drug Secures Approval In China

By Yahoo! Finance | 11 months ago

Muna-GSK alliance to fast-track Alzheimer's disease treatments

Muna-GSK alliance to fast-track Alzheimer's disease treatments

By Yahoo! Finance | 1 year ago

GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago

GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago

By Yahoo! Finance | 1 year ago

GSK gains approval in Japan for extended indication of RSV vaccine

GSK gains approval in Japan for extended indication of RSV vaccine

By Yahoo! Finance | 1 year ago

GSK eyes up combo approval for previously withdrawn myeloma drug

GSK eyes up combo approval for previously withdrawn myeloma drug

By Yahoo! Finance | 1 year ago

GSK announces Japan's MHLW approved application to extend indication of Arexvy

GSK announces Japan's MHLW approved application to extend indication of Arexvy

By Yahoo! Finance | 1 year ago

GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why

GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why

By Yahoo! Finance | 1 year ago

Health Canada approves GSK's Ojjaara for myelofibrosis in anaemia patients

Health Canada approves GSK's Ojjaara for myelofibrosis in anaemia patients

By Yahoo! Finance | 1 year ago